CNA | Chr | Start | End | Length (kb) | Cytoband | Q value | Genes in peak |
Amplification | |||||||
1 | 10 | 123 336 181 | 123 337 713 | 1.5 | 10q26.13 | 3.9561E-99 | FGFR2 |
2 | 8 | 128 628 340 | 128 670 251 | 41.9 | 8q24.21 | 7.984E-27 | [MYC] |
3 | 19 | 34 982 652 | 35 002 397 | 19.7 | 19q12 | 3.1439E-23 | CCNE1 |
4 | 12 | 25 213 920 | 25 336 398 | 122.5 | 12p12.1 | 1.5713E-14 | KRAS, CASC1, LYRM5 |
5 | 18 | 17 947 474 | 18 040 783 | 93.3 | 18q11.2 | 1.0616E-13 | GATA6 |
6 | 5 | 21 377 838 | 21 406 308 | 28.5 | 5p14.3 | 9.501E-12 | [CDH12] |
7 | 7 | 91 921 079 | 92 111 471 | 190.4 | 7q21.2 | 2.0612E-10 | CDK6, PEX1, GATAD1, DKFZP564O0523, FAM133B |
8 | 8 | 11 346 688 | 11 659 701 | 313.0 | 8p23.1 | 9.0544E-10 | BLK, GATA4, C8orf13 |
9 | 7 | 55 237 447 | 55 373 693 | 136.2 | 7p11.2 | 2.4109E-09 | EGFR |
10 | 17 | 35 102 118 | 35 136 335 | 34.2 | 17q12 | 3.8268E-09 | ERBB2 |
11 | 13 | 72 528 937 | 72 770 614 | 241.7 | 13q22.1 | 1.4729E-07 | KLF5 |
12 | 11 | 69 161 019 | 69 306 967 | 145.9 | 11q13.2 | 9.1737E-07 | CCND1, FGF4, FGF19, ORAOV1 |
13 | 7 | 115 987 034 | 116 178 774 | 191.7 | 7q31.2 | 0.00012527 | CAV1, MET |
Deletion | |||||||
1 | 3 | 60 447 451 | 60 472 964 | 25.5 | 3p14.2 | 3.4002E-41 | FHIT |
2 | 8 | 4 182 635 | 4 182 916 | 0.3 | 8p23.2 | 1.0797E-18 | CSMD1 |
3 | 9 | 21 953 419 | 21 995 192 | 41.8 | 9p21.3 | 1.0299E-17 | CDKN2A, CDKN2B |
4 | 6 | 2 019 538 | 2 068 880 | 49.3 | 6p25.3 | 1.7756E-14 | GMDS |
5 | 16 | 77 269 209 | 77 293 232 | 24.0 | 16q23.1 | 5.4871E-12 | WWOX |
6 | 6 | 162 551 244 | 162 610 874 | 59.6 | 6q26 | 2.1056E-11 | PARK2 |
7 | 13 | 47 806 677 | 47 809 375 | 2.7 | 13q14.2 | 3.3682E-11 | RB1 |
8 | 5 | 58 436 441 | 58 569 237 | 132.8 | 5q11.2 | 1.6661E-10 | PDE4D |
9 | 9 | 9 524 063 | 9 675 303 | 151.2 | 9p23 | 1.2287E-09 | PTPRD |
Focal recurrent CNA (amplifications and deletions) identified by genomic identification of significant targets in cancer (GISTIC). Genes previously reported as oncogenes or tumour suppressor genes are highlighted in bold. Start and end indicates the boundary of the region identified. Length indicates size of each region identified. Q value represents the significance of the recurrent CNA region across all the gastric tumours. Genes in peak, genes covered by the corresponding region, a square bracket indicates that the gene lies immediately adjacent to the peak.